Michael Leuchten

Stock Analyst at UBS

(1.58)

# 2,293

Out of 4,497 analysts

3

Total ratings

66.67%

Success rate

10.5%

Average return

Main Sectors:

Top Industries:

Drug Manufacturers - General Biotechnology

3 Stocks

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	NVO Novo Nordisk	Downgrades: Sell	n/a	$131.54	-	1	Jun 28, 2022
	AZN AstraZeneca	Upgrades: Buy	n/a	$78.71	-	1	Feb 25, 2021
	SNY Sanofi	Downgrades: Underweight	n/a	$50.62	-	1	Jan 23, 2018

Novo Nordisk

Jun 28, 2022

Downgrades: Sell

Price Target: n/a

Current: $131.54

Upside: -

AstraZeneca

Feb 25, 2021

Upgrades: Buy

Price Target: n/a

Current: $78.71

Upside: -

Sanofi

Jan 23, 2018

Downgrades: Underweight

Price Target: n/a

Current: $50.62

Upside: -